MedPath

Studies on skin damage by UVC at 233 nm compared to UVB in vivo

Not Applicable
Conditions
healthy subjects
Registration Number
DRKS00028055
Lead Sponsor
Charité – Universitätsmedizin Berlin,Department of Dermatology, Venerology and Allergology,Center of Experimental and Applied Cutaneous Physiology (CCP)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

male and female volunteers =18 years without skin diseases
written informed consent
skin type I–III (Fitzpatrick)
Informed about the goal and nature of the study
no intensive sun exposure on the skin sites to be irradiated (lower back) in the 14 days prior to the examinations

Exclusion Criteria

minors
breastfeeding women and women with known pregnancy
known skin diseases
skin type >III (Fitzpatrick)
intensive sun exposure on the skin sites to be irradiated (lower back) in the 14 days prior to the examinations
subjects who cannot make decisions independently

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The classical skin parameters erythema formation, transepidermal water loss, skin hydration, elasticity and pH, as well as the activation state of mast cells and macrophages in the skin 24 h after Far-UVC irradiation of 60 mJ/cm² 233 nm do not change.
Secondary Outcome Measures
NameTimeMethod
o or negligible DNA damage in the skin occurrs after Far-UVC irradiation of 60 mJ/cm² 233 nm.
© Copyright 2025. All Rights Reserved by MedPath